Oct 24 (Reuters) - Resverlogix Corp RVX.TO
* Resverlogix Corp - entered into a Right of First Refusal
Agreement with Hepalink USA Inc
* Resverlogix Corp - Hepalink USA paid $8 million to
Resverlogix in consideration for right of first refusal granted
* Resverlogix - during first 60 day period, deal may only
be terminated upon mutual agreement; thereafter, agreement may
be terminated by either party
* Resverlogix-Hepalink USA granted Right of First Refusal in
connection with licensing of right to develop, among others,
products having RVX-208 in U.S.
* Resverlogix-Hepalink USA granted Right of First Refusal
related to licensing of right to develop products with RVX-208
in U.S. until April 15, 2019
Source text for Eikon: ID:nGNXOGGTUa
Further company coverage: RVX.TO
((Bangalore.newsroom@thomsonreuters.com;;))